Skip to main content

Table 2 Plasma levels of TAFI and F 1 + 2 in the groups

From: Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

Variables Groups P-value
  Gastric cancer Control  
TAFI Level ± SD (ng/ml) 69.4 ± 33.1 73.3 ±27.5 0.41
F 1 + 2 Level (pmol/l) 549.7 ± 325.3 151.9 ± 67.1 <0.001*